BRIDGEWAY CAPITAL MANAGEMENT, LLC - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 10 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$72,000
-31.4%
153,8000.0%0.00%
-50.0%
Q4 2015$105,000
-29.5%
153,8000.0%0.00%
-33.3%
Q3 2015$149,000
+198.0%
153,800
+271.5%
0.00%
+200.0%
Q2 2015$50,000
-88.3%
41,400
-83.7%
0.00%
-93.3%
Q3 2013$427,000
+65.5%
254,200
+96.7%
0.02%
+50.0%
Q2 2013$258,000129,2000.01%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders